1-10 of 10
Hervé Maisonneuve
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90 y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

Françoise Kraeber-Bodere, MD, PhD, Amandine Pallardy, MD, Steven Le Gouill, Hervé Maisonneuve, MD, Thierry Lamy, MD, Krimo Bouabdallah, MD, Noel Milpied, MD, Henry Jardel, MD, Eric Deconinck, MD, PhD, Nadine Morineau, MD, Charles Foussard, MD, Annie Brion, MD, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, MD, Christian Berthou, MD, Francois Dreyfus, Caroline Bodet-Milin, MD, Anne-Laure Cazeau, MD, Etienne Garin, MD, PhD, Jean-Philippe Vuillez, MD, PhD, Loic Campion, MD, Philippe Moreau, MD, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Pierre Soubeyran, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 906.
https://doi.org/10.1182/blood.V120.21.906.906
Published: 2012
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010
Journal Articles

Final Results of the RiPAD+C Regimen Including Velcade In Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Roch Houot, Mario Ojeda Uribe, Christiane Mounier, Krimo Bouabdallah, Magda Alexis, MD, Delphine Senecal, Marie Pierre Molles, Olivier Tournilhac, MD, PhD, Sophie Park, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Bruno Lioure, David Assouline, MD, Jean-Luc Harousseau, Hervé Maisonneuve, Sylvie Caulet Maugendre, Steven Le Gouill
Journal: Blood
Blood (2010) 116 (21): 2791.
https://doi.org/10.1182/blood.V116.21.2791.2791
Published: 2010
Journal Articles

High Response Rate and Low Toxicity of Rituximab, Vinorelbine, Ifosfamide, Mitoxantrone and Prednisone Combination for the Treatment of Diffuse Large B Cell Lymphoma In First Relapse: Early Results of the R-NIMP GOELAMS Study.

Emmanuel Gyan, MD, PhD, Delphine Senecal, MD, Philippe Quittet, MD, Charles Foussard, MD, Anne Banos, MD, Steven Le Gouill, MD, PhD, Charles Dauriac, MD, Julie Léger, Jean Fontan, MD, Diane Damotte, MD, Hervé Maisonneuve, MD, Magda Alexis, MD, Francois Dreyfus, MD, PhD, Stéphane Courby, MD, Jean-Louis Dutel, MD, Olivier Tournilhac, MD, PhD, Kamel Laribi, MD, Philippe Solal-Céligny, MD, Annick Le Pourhiet-Le Mevel, MD, Nina Arakelyan, MD, Henry Jardel, MD, Remy Gressin, MD
Journal: Blood
Blood (2010) 116 (21): 2796.
https://doi.org/10.1182/blood.V116.21.2796.2796
Published: 2010
Journal Articles

Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine (F), Cyclophosphamide (C) and MabCampath (Cam) (FCCam) in Previously Untreated Patients (pts) with Advanced B-Chronic Lymphocytic Leukemia (B-CLL) : Experience On Safety and Efficacy within a Randomised Multicenter Phase III Trial of the french Cooperative Group On CLL and WM (FCGCLL/MW) and the “Groupe Ouest-Est d'Etudes Des Leucémies Aigües Et Autres Maladies Du sang” (GOELAMS) : CLL2007FMP (for fit medically patients).

Stephane Lepretre, Therese Aurran, Beatrice Mahe, Bruno Cazin, Olivier Tournihlac, Hervé Maisonneuve, Olivier Casasnovas, Alain Delmer, Veronique Leblond, Bruno Royer, Brigitte Corront, Sylvie Chevret, Roselyne Delepine, Sandrine Vaudaux, Eric Van Den Neste, marie-Christine Béné, Florence Cymbalista, Pierre Feugier
Journal: Blood
Blood (2009) 114 (22): 538.
https://doi.org/10.1182/blood.V114.22.538.538
Published: 2009
Journal Articles

Interest and Prognosis Value of Fluorine-18-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography ([ 18 F] FDG-PET/CT) in Aggressive T-Cell Lymphomas

Xavier Cahu, Caroline Bodet-Milin, Thomas Gastinne, Hervé Maisonneuve, Nadine Morineau, Gandhi Damaj, Philippe Solal-Celigny, Philippe Moreau, Henri Jardel, Philippe Moreau, Jean-Luc Harousseau, Françoise Kraeber-Bodéré, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2835.
https://doi.org/10.1182/blood.V112.11.2835.2835
Published: 2008
Journal Articles

Prolonged PFS after Autologous Stem Cell Transplantation in Follicular Lymphoma Patients: A Long-Term Retrospective Study.

Violaine Safar, Thomas Gastinne, Noel Milpied, MD, Hervé Maisonneuve, Nadine Morineau, Viviane Dubruille, Beatrice Mahé, Philippe Moreau, Henri Jardel, Lucie Planche, Philippe Moreau, Jean-Luc Harousseau, Steven Le Gouill, MD
Journal: Blood
Blood (2008) 112 (11): 2190.
https://doi.org/10.1182/blood.V112.11.2190.2190
Published: 2008
Journal Articles

Prognosis Value of [ 18 f] FDG-PET Prior Versus after Autologous Stem Cells Transplantation in High Grade Non-Hodgkin’s Lymphoma.

Virginie Roland, Caroline Bodet Milin, Anne Moreau, Thomas Gastinne, Beatrice Mahe, Viviane Dubruille, Hervé Maisonneuve, Nadine Morineau, Philippe Moreau, Henri Jardel, Lucie Planche, Philippe Moreau, Jean- Luc Harousseau, Françoise Kraeber bodere, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2177.
https://doi.org/10.1182/blood.V112.11.2177.2177
Published: 2008
Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Clinical Trials & Observations
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud, Alain Sadoun, Laurent Voillat, Véronique Dorvaux, Cyrille Hulin, Gérard Lepeu, Jean-Luc Harousseau, Jean-Paul Eschard, Augustin Ferrant, Michel Blanc, Frédéric Maloisel, Hubert Orfeuvre, Jean-François Rossi, Isabelle Azaïs, Mathieu Monconduit, Philippe Collet, Bruno Anglaret, Ibrahim Yakoub-Agha, Marc Wetterwald, Houchingue Eghbali, Marie-Christine Vekemans, Hervé Maisonneuve, Jacques Troncy, Bernard Grosbois, Chantal Doyen, Antoine Thyss, Jérome Jaubert, Philippe Casassus, Béatrice Thielemans, Régis Bataille, for the Intergroupe Francophone du Myélome (IFM) group
Journal: Blood
Blood (2006) 107 (4): 1292–1298.
https://doi.org/10.1182/blood-2005-04-1588
Published: 2006
Journal Articles

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial

Clinical Trials & Observations
Christine le Maignan, Bernard Desablens, Vincent Delwail, Mahmoud Dib, Christian Berthou, Magda Vigier, Christiane Ghandour, Saïd Atmani, Philippe Casassus, Hervé Maisonneuve, Annick Le Mevel, Catherine Traullé, Marc Bernard, Josette Brière, Pierre Colonna, Jean-Marie Andrieu
Journal: Blood
Blood (2004) 103 (1): 58–66.
https://doi.org/10.1182/blood-2003-05-1611
Published: 2004